HTG Molecular Diagnostics Inc is a United States-based company that provides products for miRNA, and mRNA measurement for translational research/medicine and molecular diagnostics. Its qNPA molecular technology platform is suited for detecting changes in gene expression levels; especially from formalin-fixed, paraffin-embedded (FFPE) tissue and other biological sample types. Its products include HTG Edge System, HTG Edge Assays and HTG Assay Direct. The HTG Edge System an automated RNA analysis platform that delivers extraction-free, multiplexed results on a multitude of biological samples (tissue, blood, serum, cells) in less than 24 hours. HTG Edge DMPK Assay is a 47-gene assay that enables researchers to characterize drug metabolism in pre-clinical studies. HTG Edge Top Oncogene Assay measures the expression levels of 32 of the most commonly assayed oncogenes in fresh or fixed biological specimens.